Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations (Q27853374)

1

0 references

Y C Elala

2

0 references

T L Lasho

3

0 references

K H Begna

4

0 references

N Gangat

5

0 references

C Finke

6

0 references

C A Hanson

7

0 references

R P Ketterling

8

0 references

A Pardanani

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

9

0 references

publication date

8 April 2016

0 references

published in

Blood Cancer Journal

0 references

volume

6

0 references

issue

4

0 references

page(s)

e415

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4855254

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4855254

Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4855254

Somatic mutations of calreticulin in myeloproliferative neoplasms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4855254

Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4855254

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4855254

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4855254

Mutations and prognosis in primary myelofibrosis

29 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBCJ.2016.22

U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBCJ.2016.22

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27058230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Struggling with myelofibrosis-associated anemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27058230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

SRSF2 mutations in primary myelofibrosis: significant clustering with IDH mutations and independent association with inferior overall and leukemia-free survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27058230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BCJ.2016.22

1 reference

Dimensions Publication ID

2415979

1053071657

0 references

2415979

1 reference

1 reference

1 reference